100 related articles for article (PubMed ID: 25948176)
41. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease.
Choi SJ; Oba Y; Gazitt Y; Alsina M; Cruz J; Anderson J; Roodman GD
J Clin Invest; 2001 Dec; 108(12):1833-41. PubMed ID: 11748267
[TBL] [Abstract][Full Text] [Related]
42. The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.
Tsubaki M; Takeda T; Tomonari Y; Mashimo K; Koumoto YI; Hoshida S; Itoh T; Imano M; Satou T; Sakaguchi K; Nishida S
J Cell Physiol; 2018 May; 233(5):4258-4271. PubMed ID: 29057477
[TBL] [Abstract][Full Text] [Related]
43. Role of CCL3 protein (monocyte inflammatory protein-1 alpha) in lymphoid malignancy.
Hamed H; Zaki S
Egypt J Immunol; 2007; 14(1):63-72. PubMed ID: 18689282
[TBL] [Abstract][Full Text] [Related]
44. Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition.
Ottersbach K; Cook DN; Kuziel WA; Humbles A; Lu B; Gerard C; Proudfoot AE; Graham GJ
Blood; 2001 Dec; 98(12):3476-8. PubMed ID: 11719391
[TBL] [Abstract][Full Text] [Related]
45. Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma.
Terpos E; Politou M; Szydlo R; Goldman JM; Apperley JF; Rahemtulla A
Br J Haematol; 2003 Oct; 123(1):106-9. PubMed ID: 14510950
[TBL] [Abstract][Full Text] [Related]
46. Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma.
Hashimoto T; Abe M; Oshima T; Shibata H; Ozaki S; Inoue D; Matsumoto T
Br J Haematol; 2004 Apr; 125(1):38-41. PubMed ID: 15015966
[TBL] [Abstract][Full Text] [Related]
47. Role of macrophage inflammatory protein-1alpha (MIP-1alpha) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi.
Petray P; Corral R; Meckert P; Laguens R
Acta Trop; 2002 Sep; 83(3):205-11. PubMed ID: 12204393
[TBL] [Abstract][Full Text] [Related]
48. Pre-treatment of peripheral blood progenitor cells with macrophage inflammatory protein-1alpha induces prolonged survival of early progenitor cells over 6 weeks of long-term culture.
Egger D; Günther C; Helbig W; Schulze E
Br J Haematol; 1998 Dec; 103(4):1181-3. PubMed ID: 9886339
[TBL] [Abstract][Full Text] [Related]
49. MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma.
Masih-Khan E; Trudel S; Heise C; Li Z; Paterson J; Nadeem V; Wei E; Roodman D; Claudio JO; Bergsagel PL; Stewart AK
Blood; 2006 Nov; 108(10):3465-71. PubMed ID: 16849642
[TBL] [Abstract][Full Text] [Related]
50. Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.
Shu ST; Dirksen WP; Lanigan LG; Martin CK; Thudi NK; Werbeck JL; Fernandez SA; Hildreth BE; Rosol TJ
Leuk Lymphoma; 2012 Apr; 53(4):688-98. PubMed ID: 21942940
[TBL] [Abstract][Full Text] [Related]
51. Role of macrophage inflammatory protein (MIP)-1α/CCL3 in leukemogenesis.
Baba T; Mukaida N
Mol Cell Oncol; 2014; 1(1):e29899. PubMed ID: 27308309
[TBL] [Abstract][Full Text] [Related]
52. [MIP-1α promotes the migration ability of Jurkat cell through human brain microvascular endothelial cell monolayer].
Ma YR; Zhang S; Sun Y; Liu YY; Song Q; Hao YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):35-9. PubMed ID: 24598647
[TBL] [Abstract][Full Text] [Related]
53. Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1a) in human multiple myeloma.
Hata H
Leuk Lymphoma; 2005 Jul; 46(7):967-72. PubMed ID: 16019547
[TBL] [Abstract][Full Text] [Related]
54. Relation between macrophage inflammatory protein-1 and intercellular adhesion molecule-1 and computed tomography findings in critically-ill saudi covid-19 patients.
Hamza AM; Ali WDK; Hassanein N; Albassam WB; Barry M; AlFaifi AMM; Altayyar KAS; Aboabat NAM; Alshaiddi WKF; AbuSabbah HMH; Alamri AH; Albabtain SAH; Alsayed E
J Infect Public Health; 2022 Dec; 15(12):1497-1502. PubMed ID: 36423464
[TBL] [Abstract][Full Text] [Related]
55. 3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance.
Alhallak K; de la Puente P; Jeske A; Sun J; Muz B; Rettig MP; Sahin I; Weisberg EL; Griffin JD; Reagan JL; DiPersio JF; Azab AK
Leuk Lymphoma; 2021 Oct; 62(10):2457-2465. PubMed ID: 33993837
[TBL] [Abstract][Full Text] [Related]
56. C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
Anderson MW; Zhao S; Ai WZ; Tibshirani R; Levy R; Lossos IS; Natkunam Y
Am J Clin Pathol; 2010 Mar; 133(3):473-83. PubMed ID: 20154287
[TBL] [Abstract][Full Text] [Related]
57. CCL3 Signaling in the Tumor Microenvironment.
Ntanasis-Stathopoulos I; Fotiou D; Terpos E
Adv Exp Med Biol; 2020; 1231():13-21. PubMed ID: 32060842
[TBL] [Abstract][Full Text] [Related]
58. A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators.
Brenner AK; Reikvam H; Bruserud Ø
Front Immunol; 2016; 7():205. PubMed ID: 27252705
[TBL] [Abstract][Full Text] [Related]
59. Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma.
Tsirakis G; Roussou P; Pappa CA; Kolovou A; Vasilokonstantaki C; Miminas I; Kyriakaki S; Alegakis A; Alexandrakis MG
Med Oncol; 2014 Jan; 31(1):778. PubMed ID: 24277416
[TBL] [Abstract][Full Text] [Related]
60. Stearic Acid and TNF-α Co-Operatively Potentiate MIP-1α Production in Monocytic Cells via MyD88 Independent TLR4/TBK/IRF3 Signaling Pathway.
Kochumon S; Arefanian H; Azim R; Shenouda S; Jacob T; Abu Khalaf N; Al-Rashed F; Hasan A; Sindhu S; Al-Mulla F; Ahmad R
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33050324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
